Abstract:Background: Influenza neuraminidase (NA) is an important target for antiviral inhibitors since its active site is highly conserved such that inhibitors can be cross-reactive against multiple types and subtypes of influenza. Here, we discuss the crystal structure of neuraminidase subtype N9 complexed with a new benzoic acid based inhibitor (2) that was designed to add contacts by overpacking one side of the active site pocket. Inhibitor 2 uses benzoic acid to mimic the pyranose ring, a bis-(hydroxymethyl)-substituted 2-pyrrolidinone ring in place of the N-acetyl group of the sialic acid, and a branched aliphatic structure to fill the sialic acid C6 subsite. Results: Inhibitor 2 {4-[2,2-bis(hydroxymethyl)-5-oxo-pyrrolidin-1-yl]-3-[(dipropylamino)methyl)]benzoic acid} was soaked into crystals of neuraminidase of A/tern/Australia/G70c/75 (N9), and the structure refined with 1.55 Å X-ray data. The benzene ring of the inhibitor tilted 8.9° compared to the previous compound (1), and the number of contacts, including hydrogen bonds, increased. However, the IC50 for compound 2 remained in the low micromolar range, likely because one propyl group was disordered. In this high-resolution structure of NA isolated from virus grown in chicken eggs, we found electron density for additional sugar units on the N-linked glycans compared to previous neuraminidase structures. In particular, seven mannoses and two N-acetylglucosamines are visible in the glycan attached to Asn200. This long, branched high-mannose glycan makes significant contacts with the neighboring subunit. Conclusions: We designed inhibitor 2 with an extended substituent at C4-corresponding to C6 of sialic acid-to increase the contact surface in the C6-subsite and to force the benzene ring to tilt to maximize these interactions while retaining the interactions of the carboxylate and the pyrolidinone substituents. The crystal structure at 1.55 Å showed that we partially succeeded in that the ring in 2 is tilted relative to 1 and the number of contacts increased, but one hydrophobic branch makes no contacts, perhaps explaining why the IC50 did not decrease. Future design efforts will include branches of unequal length so that both branches may be accommodated in the C6-subsite without conformational disorder. The high-mannose glycan attached to Asn200 makes several inter-subunit contacts and appears to stabilize the tetramer.

ChemInform Abstract: Binding Interaction Analysis of the Active Site and Its Inhibitors for Neuraminidase (N1 Subtype) of Human Influenza Virus by the Integration of Molecular Docking, FMO Calculation and 3D‐QSAR CoMFA Modeling.

ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

Computational Identification of a New Binding Site in Influenza Virus Hemagglutinin for Membrane Fusion Inhibitors

Discovering Neuraminidase Inhibitors via Computational and Experimental Studies

Develop integration modeling approach for discovery neuraminidase inhibitors in silico based on pharmacophore and CoMSIA models

MedChemExpress compounds prevent neuraminidase N1 via physics- and knowledge-based methods

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico.

Design, synthesis, bioactivity, and DFT calculation of 2-thiazolyl-hydrazone derivatives as influenza neuraminidase inhibitors

Computational Studies On The Substrate Interactions Of Influenza A Virus Pb2 Subunit

Complement activation by bisretinoid constituents of RPE lipofuscin.

Virtual Screening and Molecular Growth Guide the Design of Inhibitors for the Influenza Virus Drug-Resistant Mutant M2-V27A/S31N.

ChemInform Abstract: Synthesis and HIV‐1 Integrase Inhibition Activity of Some N‐Arylindoles.

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors

ChemInform Abstract: Three‐Component, One‐Pot Synthesis of Novel 2,4‐substituted 5‐azolylthiopyrimidine Library for Screening Against Antiinfluenza Virus A.

Rational Design of Tamiflu Derivatives Targeting at the Open Conformation of Neuraminidase Subtype 1

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico

Design, Synthesis and Biological Evaluation of "Multi-Site"-binding Influenza Virus Neuraminidase Inhibitors.

ChemInform Abstract: 3D QSAR Analyses of Novel Tyrosine Kinase Inhibitors Based on Pharmacophore Alignment.

Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6

Structural and free energy landscape analysis for the discovery of antiviral compounds targeting the cap-binding domain of influenza polymerase PB2

ChemInform Abstract: Synthesis and Biological Evaluation of Novel Isopropanolamine Derivatives As Non‐Peptide Human Immunodeficiency Virus Protease Inhibitors.